Your session is about to expire
← Back to Search
Procedure
1 for Colorectal Cancer (COLORII Trial)
Phase 3
Waitlist Available
Led By Jaap Bonjer, MD, PhD
Research Sponsored by Jaap Bonjer
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up seven years
Awards & highlights
COLORII Trial Summary
COLOR II is a randomized, international, multi center study comparing the outcomes of laparoscopic and conventional resection of rectal carcinoma below 15 cm with curative intent. Clinical and operative data will be collected centrally in the coordinating centre in Halifax, Canada. Quality of life and costs will be assessed on a national basis.
Eligible Conditions
- Colorectal Cancer
COLORII Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ seven years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~seven years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
locoregional recurrence rate
Secondary outcome measures
distant metastases rate
duration of absence of work
duration of in-hospital stay
+8 moreCOLORII Trial Design
1Treatment groups
Experimental Treatment
Group I: 1Experimental Treatment1 Intervention
surgery (open or laparoscopic) and observation
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
surgery
2005
Completed Phase 4
~6010
Find a Location
Who is running the clinical trial?
Jaap BonjerLead Sponsor
Jaap Bonjer, MD, PhDPrincipal InvestigatorDalhousie University, and VUMC, the Netherlands
1 Previous Clinical Trials
1,200 Total Patients Enrolled
Marius HoogerboordPrincipal InvestigatorNova Scotia Health Authority
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger